Long-term outcome of the survivors of infantile hypercalcaemia with <i>CYP24A1</i> and <i>SLC34A1</i> mutations
Agnieszka Janiec(Children's Memorial Health Institute), Mieczysław Litwin(Children's Memorial Health Institute), Paulina Halat-Wolska(Children's Memorial Health Institute), Ewa Pronicka(Children's Memorial Health Institute), Janusz Książyk(Children's Memorial Health Institute), Zbigniew Kułaga(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Paweł Płudowski(Children's Memorial Health Institute), Ewa Kowalska(Children's Memorial Health Institute), Marek Wójcik(Children's Memorial Health Institute), Aldona Wierzbicka(Children's Memorial Health Institute), Łukasz Obrycki(Children's Memorial Health Institute)
Cited by 28
Related Papers
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
|Journal of Hypertension|2016|1.4k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233
Clinical implementation of RNA sequencing for Mendelian disease diagnostics
|Genome Medicine|2022|215